Trial site
Texas Oncology - Fort Worth Cancer Center
- 10running trials
- 11closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Ovarian cancer4 trials
- Chronic lymphocytic leukaemia3 trials
- Prostate cancer3 trials
- Cervical cancer2 trials
- Pancreatic cancer2 trials
- Triple-negative breast cancer2 trials
- Bladder cancer1 trial
- Childhood cancers1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Glioblastoma1 trial
- and 2 more
- Phase
- Phase 27 trials
- Phase 37 trials
- Phase 1/23 trials
- Phase 12 trials
- Phase 2/32 trials
- Status
- Active, not recruiting7 trials
- Completed6 trials
- Terminated5 trials
- Recruiting3 trials
- Suspended1 trial
- Lead sponsor
- National Cancer Institute (NCI)3 trials
- Janssen Research & Development, LLC2 trials
- NRG Oncology2 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- Verastem, Inc.2 trials
- and 11 more
Running trials
Active, not recruiting
Recruiting
Recruiting
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Terminated
Terminated
Completed
A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Completed
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
Completed
Terminated
Terminated
A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas
Completed
Terminated
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026